ProtonDx

📍 London, United Kingdom🗓 Founded 2020👥 18 employees💰 Last funded Sep 2021
Medical Equipment Manufacturing🌐 protondx.com
Website LinkedIn
ProtonDx is revolutionising the world of rapid, molecular testing at point of need. Our goal is to ensure specific viral detection diagnosis uncertainty is a thing of the past. Our expertise is in cutting edge electronics, molecular biology, and machine learning which we have blended together to create novel portable connected devices. Powered by highly sensitive LAMP technology, these are providing new robust methods to identify multiple pathogens, quickly and accurately. This approach puts us at the forefront in the global fight against antimicrobial resistance. Spun out of Imperial College London in March 2020, ProtonDx ambition is to ensure tests can be conducted quickly, accurately and cost effectively, wherever and whenever they are needed throughout the world so that all can benefit from advances in technology. Our innovative lab on a chip technology has already received many awards including the 2020 IEEE CASS COVID 19 Entrepreneur’s award, the IEEE Sensors Technical Achievement award, IET Mike Sergeant Achievement Medal, Rosetrees Trust Interdisciplinary Prize, Wellcome Trust Innovator Award, two Imperial Techcelerate Awards, MedTech SuperConnector Award, and various other IEEE awards.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in ProtonDx?
ProtonDx has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ProtonDx last raise funding?
The most recent investment in ProtonDx recorded on gritt.io was in September 2021.
When was ProtonDx founded?
ProtonDx was founded in 2020.
What industry is ProtonDx in?
ProtonDx operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is ProtonDx based?
ProtonDx is headquartered in London, United Kingdom.